There is no evidence that EC coating of low dose aspirin reduced GI side effects.
EC preparations are more expensive than plain tablets
Nefopam
Non Formulary
Nefopam (Acupan®)
Non Formulary
Paracetamol and codeine (Co-codamol® 8/500) (Capsule)
Non Formulary
Tablets are more cost-effective.
Paracetamol and dextropropoxyphene (Co-proxamol®)
Non Formulary
Previously ‘non-formulary’. Updating in line with NHS England Items which should not routinely be prescribed in primary care guidance
APCO September 2019.
Paracetamol and dihydrocodeine (Co-dydramol®)
Non Formulary
Now available as:
Co-dydramol 10/500 mg
Co-dydramol 20/500 mg
Co-dydramol 30/500 mg
It is therefore important that co-dydramol products are prescribed and dispensed by strength to minimise dispensing errors and the risk of accidental opioid overdose.
Red: Medicines which should only be prescribed in secondary care by a specialist.
Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.
Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).
Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.
Brown: Medicines which should only be prescribed in restricted circumstances.
Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.
Restricted
